SDPC Stock Overview
Engages in the distribution and trading of prescription and non-prescription medicines and medical devices in Indonesia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
PT Millennium Pharmacon International Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp132.00 |
| 52 Week High | Rp183.00 |
| 52 Week Low | Rp121.00 |
| Beta | 0.59 |
| 1 Month Change | -1.49% |
| 3 Month Change | -3.65% |
| 1 Year Change | -16.46% |
| 3 Year Change | -5.04% |
| 5 Year Change | 28.16% |
| Change since IPO | 654.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| SDPC | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | 1.5% | 4.3% | 2.0% |
| 1Y | -16.5% | 21.6% | 6.1% |
Return vs Industry: SDPC underperformed the ID Healthcare industry which returned 20.1% over the past year.
Return vs Market: SDPC underperformed the ID Market which returned 3% over the past year.
Price Volatility
| SDPC volatility | |
|---|---|
| SDPC Average Weekly Movement | 8.3% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in ID Market | 12.7% |
| 10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: SDPC has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: SDPC's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | 1,172 | Ahmad Bin Abu Bakar | www.mpi-indonesia.co.id |
PT Millennium Pharmacon International Tbk engages in the distribution and trading of prescription and non-prescription medicines and medical devices in Indonesia. As of December 31, 2022, it operated 33 branch offices in Java, Bali, Sumatera, Kalimantan, and Sulawesi Islands. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990.
PT Millennium Pharmacon International Tbk Fundamentals Summary
| SDPC fundamental statistics | |
|---|---|
| Market cap | Rp168.17b |
| Earnings (TTM) | Rp26.87b |
| Revenue (TTM) | Rp3.85t |
6.3x
P/E Ratio0.0x
P/S RatioIs SDPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SDPC income statement (TTM) | |
|---|---|
| Revenue | Rp3.85t |
| Cost of Revenue | Rp3.52t |
| Gross Profit | Rp326.25b |
| Other Expenses | Rp299.37b |
| Earnings | Rp26.87b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 21.09 |
| Gross Margin | 8.48% |
| Net Profit Margin | 0.70% |
| Debt/Equity Ratio | 295.5% |
How did SDPC perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield12%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 06:28 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PT Millennium Pharmacon International Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|